NTLA · Intellia Therapeutics, Inc.
$11.91
+0.08 (+0.68%)
At close · Aug 14
Market Cap
$1.67B
Shares
140.13M
Weekly off-exchange (dark pool / OTC) trading volume reported to FINRA under its OTC/ATS Transparency data. ATS volume is executed on alternating trading systems (dark pools); non-ATS OTC is other over-the-counter dealer volume. The off-exchange share is total off-exchange volume as a percentage of consolidated weekly trading volume for the same Monday–Friday week.
Off-Exchange Volume History
| Week Start | ATS Volume | Non-ATS OTC Volume | Total Off-Exchange | % of FINRA Weekly Volume |
|---|---|---|---|---|
| 2026-07-06 | 4,630,050 | 6,300,208 | 10,930,258 | 45.3% |
| 2026-06-29 | 3,359,274 | 3,670,370 | 7,029,644 | 40.7% |
| 2026-06-22 | 3,694,489 | 6,998,000 | 10,692,489 | 39.7% |
| 2026-06-15 | 6,450,558 | 11,186,042 | 17,636,600 | 38.1% |
| 2026-06-08 | 5,214,562 | 6,829,067 | 12,043,629 | 38.6% |
| 2026-06-01 | 4,349,063 | 8,414,567 | 12,763,630 | 46.1% |
| 2026-05-25 | 2,738,487 | 7,088,407 | 9,826,894 | 48.6% |
| 2026-05-18 | 4,515,597 | 6,313,501 | 10,829,098 | 39.1% |
| 2026-05-11 | 7,134,280 | 9,916,540 | 17,050,820 | 38.2% |
| 2026-05-04 | 4,084,472 | 7,280,922 | 11,365,394 | 45.4% |
| 2026-04-27 | 15,661,063 | 23,776,883 | 39,437,946 | 44.6% |
| 2026-04-20 | 3,755,358 | 7,094,767 | 10,850,125 | 42.9% |
| 2026-04-13 | 2,074,361 | 4,911,750 | 6,986,111 | 44.5% |
| 2026-04-06 | 1,706,586 | 2,993,131 | 4,699,717 | 44.6% |
| 2026-03-30 | 2,348,233 | 3,741,040 | 6,089,273 | 44.8% |
| 2026-03-23 | 4,093,397 | 5,167,445 | 9,260,842 | 48.5% |
| 2026-03-16 | 2,930,325 | 4,206,221 | 7,136,546 | 43.0% |
| 2026-03-09 | 2,816,255 | 4,723,516 | 7,539,771 | 47.0% |
| 2026-03-02 | 7,814,346 | 7,796,207 | 15,610,553 | 43.0% |
| 2026-02-23 | 2,919,395 | 4,199,590 | 7,118,985 | 45.6% |
| 2026-02-16 | 1,606,734 | 2,425,048 | 4,031,782 | 42.6% |
| 2026-02-09 | 2,808,094 | 5,074,164 | 7,882,258 | 48.7% |
| 2026-02-02 | 4,010,702 | 6,590,452 | 10,601,154 | 47.6% |
| 2026-01-26 | 5,131,128 | 13,831,015 | 18,962,143 | 50.2% |
| 2026-01-19 | 5,946,786 | 13,746,898 | 19,693,684 | 52.6% |
| 2026-01-12 | 5,171,148 | 9,067,760 | 14,238,908 | 45.4% |
| 2026-01-05 | 4,857,472 | 7,921,107 | 12,778,579 | 44.4% |
| 2025-12-29 | 2,024,787 | 4,073,307 | 6,098,094 | 51.0% |
| 2025-12-22 | 1,768,290 | 2,509,833 | 4,278,123 | 48.9% |
| 2025-12-15 | 3,287,735 | 5,484,095 | 8,771,830 | 44.6% |
| 2025-12-08 | 2,893,060 | 4,425,167 | 7,318,227 | 46.2% |
| 2025-12-01 | 3,545,530 | 8,793,818 | 12,339,348 | 52.4% |
| 2025-11-24 | 2,868,980 | 4,686,727 | 7,555,707 | 50.6% |
| 2025-11-17 | 4,792,243 | 6,497,627 | 11,289,870 | 40.1% |
| 2025-11-10 | 8,172,504 | 11,589,229 | 19,761,733 | 44.8% |
| 2025-11-03 | 9,849,584 | 15,373,612 | 25,223,196 | 45.6% |
| 2025-10-27 | 18,040,978 | 33,865,160 | 51,906,138 | 45.1% |
| 2025-10-20 | 3,637,835 | 6,980,922 | 10,618,757 | 43.1% |
| 2025-10-13 | 3,740,709 | 8,459,207 | 12,199,916 | 46.5% |
| 2025-10-06 | 6,083,661 | 15,382,020 | 21,465,681 | 48.6% |
| 2025-09-29 | 4,799,277 | 8,648,182 | 13,447,459 | 45.1% |
| 2025-09-22 | 4,813,435 | 12,369,130 | 17,182,565 | 48.2% |
| 2025-09-15 | 7,568,328 | 16,635,654 | 24,203,982 | 48.4% |
| 2025-09-08 | 3,270,621 | 6,924,785 | 10,195,406 | 43.9% |
| 2025-09-01 | 2,822,708 | 5,384,253 | 8,206,961 | 50.4% |
| 2025-08-25 | 3,964,192 | 4,850,654 | 8,814,846 | 47.3% |
| 2025-08-18 | 3,455,258 | 4,297,642 | 7,752,900 | 42.2% |
Showing 1–47 of 47 weeks
Key facts
CIK
1652130
CUSIP
45826J105
13F (30d)
334 filings
307 filers
Visit website
Investor relations